Related Articles
Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats
Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro
Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline
Effect of saxagliptin on the expression of HIF‑1α in the liver of diabetic rats with fatty liver